苏州规划 reported revenue of ¥0.07B for the period ended 2026-06-30, -32.5% year on year. Net income was ¥-0.02B, a -21.7% net margin on a 16.1% gross margin. The largest revenue line is 工程设计 at 58% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.07B | -32.5% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | -406.2% |
| Gross margin | 16.1% | Net margin -21.7% |
| Revenue Q/Q | -25.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 工程设计 | ¥0.04B | 58.3% |
| 规划设计 | ¥0.02B | 34.7% |
| 其他(补充) | ¥0.00B | 4.2% |
| 智慧城市/交通 | ¥0.00B | 2.7% |
| 工程总承包及管理 | ¥0.00B | 0.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 83.9% |
| R&D | ¥0.01B | 11.3% |
| SG&A | ¥0.02B | 28.2% |
| Tax & other | ¥-0.00B | -5.0% |
| Item | Amount |
|---|---|
| Total assets | ¥1.27B |
| Total liabilities | ¥0.32B |
| Shareholders' equity | ¥0.95B |
| Equity / assets | 74.9% |
| Operating cash flow | ¥-0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | 97% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
民生健康 ・ 中机认检 ・ 金凯生科 ・ 固高科技 ・ 德福科技 ・ 智信精密 ・ 尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies